ClinicalTrials.Veeva

Menu

Mild and Moderate Aortic Regurgitation: Risk Factors for Progress and Outcome

U

Uppsala University

Status

Not yet enrolling

Conditions

Aortic Regurgitation

Study type

Observational

Funder types

Other

Identifiers

NCT07104968
2025-02671-01

Details and patient eligibility

About

This observational study aims to evaluate risk factors of progress and adverse outcome of aortic regurgitation

Full description

Aortic regurgitation is relatively common, with a prevalence of 13% for men and 8,5% for women in the Framingham study (Singh et al). Patients with aortic regurgitation are evaluated regularly with echocardiography to see if progress occurs, and suitable candidates are referred for surgical repair or replacement of the aortic valve.

However, an American study from 2019 showed that only 12% of cases of aortic regurgitation progressed from mild to moderate or severe over a 10 years period (Yang et al). This means that the majority of patients undergo echocardiographic evaluations without a clinical benefit.

It is unclear whether these findings also apply to a Swedish population with the European definitions for aortic regurgitation.

Aim:

To do a retrospective analysis of patients evaluated with echocardiography in Västerås, Sweden between January 2003 and March 2025 to describe the prevalence of aortic regurgitation as well as aortic dilatation, to describe how often progress occurs in patients with mild or moderate aortic regurgitation, and finally to look at factors (clinical, echocardiographic) associated with progress of aortic regurgitation as well as outcome (mortality, MACE, cardiac surgery).

Enrollment

35,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients investigated with echocardiography between January 2003 and March 2025
  • Age ≥18 years
  • At least minimal aortic regurgitation
  • At least one additional echocardiography after the index investigation

Exclusion criteria

  • Age <18 years

Trial design

35,000 participants in 1 patient group

Patients with aortic regurgitation
Description:
Observational study, no interventions

Trial contacts and locations

1

Loading...

Central trial contact

Matthijs Velders, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems